Literature DB >> 23397474

Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population.

Zhijun Li1, Suzhen Bao, Xiaohong Xu, Yejiang Bao, Yongjun Zhang.   

Abstract

AIM: To explore the potential association between single-nucleotide polymorphisms (SNPs) and haplotypes of the CHRNA5-CHRNA3-CHRNB4 gene cluster and the non-small cell lung cancer (NSCLC) susceptibility in never-smoking Chinese.
METHODS: A case-control study was conducted with 200 NSCLC patients and 200 healthy controls, matched on age and sex. Five SNPs distributed in CHRNA5-CHRNA3-CHRNB4 gene cluster were selected for genotyping. The association between genotype and lung cancer risk was evaluated by computing the odds ratio (OR) and 95% confidence interval (CI) from multivariate unconditional logistic regression analyses with adjustment for gender and age.
RESULTS: For CHRNA3 rs578776 status, data were available in 199 NSCLC patients and 199 controls. The G/G homozygote in CHRNB4 rs7178270 had a reduced risk of developing NSCLC (OR = 0.553; 95% CI = 0.309-0.989; P = .0437), especially squamous cell carcinoma (SQC) (OR = 0.344; 95% CI = 0.161-0.732; P = .0043), compared with those who carry at least one C allele (C/C and C/G). The polymorphisms of rs578776, rs938682, rs17486278, and rs11637635 were not significantly different between controls and cases or between controls and histologic subgroups, adenocarcinoma and SQC, respectively.
CONCLUSIONS: In our study, we found that the SNP of CHRNB4 rs7178270 is significantly associated with reduced risk of NSCLC, especially with reduced risk of SQC in never-smoking Chinese population.

Entities:  

Year:  2012        PMID: 23397474      PMCID: PMC3567724          DOI: 10.1593/tlo.12304

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  23 in total

1.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

2.  Variants in nicotinic receptors and risk for nicotine dependence.

Authors:  Laura Jean Bierut; Jerry A Stitzel; Jen C Wang; Anthony L Hinrichs; Richard A Grucza; Xiaoling Xuei; Nancy L Saccone; Scott F Saccone; Sarah Bertelsen; Louis Fox; William J Horton; Naomi Breslau; John Budde; C Robert Cloninger; Danielle M Dick; Tatiana Foroud; Dorothy Hatsukami; Victor Hesselbrock; Eric O Johnson; John Kramer; Samuel Kuperman; Pamela A F Madden; Kevin Mayo; John Nurnberger; Ovide Pomerleau; Bernice Porjesz; Oliver Reyes; Marc Schuckit; Gary Swan; Jay A Tischfield; Howard J Edenberg; John P Rice; Alison M Goate
Journal:  Am J Psychiatry       Date:  2008-06-02       Impact factor: 18.112

3.  Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors.

Authors:  Goodarz Danaei; Stephen Vander Hoorn; Alan D Lopez; Christopher J L Murray; Majid Ezzati
Journal:  Lancet       Date:  2005-11-19       Impact factor: 79.321

4.  Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21.

Authors:  Gary M Clark; Denni M Zborowski; Pedro Santabarbara; Keyue Ding; Marlo Whitehead; Lesley Seymour; Frances A Shepherd
Journal:  Clin Lung Cancer       Date:  2006-05       Impact factor: 4.785

5.  Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Authors:  Ming-Sound Tsao; Akira Sakurada; Jean-Claude Cutz; Chang-Qi Zhu; Suzanne Kamel-Reid; Jeremy Squire; Ian Lorimer; Tong Zhang; Ni Liu; Manijeh Daneshmand; Paula Marrano; Gilda da Cunha Santos; Alain Lagarde; Frank Richardson; Lesley Seymour; Marlo Whitehead; Keyue Ding; Joseph Pater; Frances A Shepherd
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

Review 6.  Lung cancer in Asian women-the environment and genes.

Authors:  Wah Kit Lam
Journal:  Respirology       Date:  2005-09       Impact factor: 6.424

7.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.

Authors:  Scott F Saccone; Anthony L Hinrichs; Nancy L Saccone; Gary A Chase; Karel Konvicka; Pamela A F Madden; Naomi Breslau; Eric O Johnson; Dorothy Hatsukami; Ovide Pomerleau; Gary E Swan; Alison M Goate; Joni Rutter; Sarah Bertelsen; Louis Fox; Douglas Fugman; Nicholas G Martin; Grant W Montgomery; Jen C Wang; Dennis G Ballinger; John P Rice; Laura Jean Bierut
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

8.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.

Authors:  Rayjean J Hung; James D McKay; Valerie Gaborieau; Paolo Boffetta; Mia Hashibe; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Chu Chen; Gary Goodman; John K Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; John McLaughlin; Geoffrey Liu; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Kristian Hveem; Lars Vatten; Jakob Linseisen; Françoise Clavel-Chapelon; Paolo Vineis; H Bas Bueno-de-Mesquita; Eiliv Lund; Carmen Martinez; Sheila Bingham; Torgny Rasmuson; Pierre Hainaut; Elio Riboli; Wolfgang Ahrens; Simone Benhamou; Pagona Lagiou; Dimitrios Trichopoulos; Ivana Holcátová; Franco Merletti; Kristina Kjaerheim; Antonio Agudo; Gary Macfarlane; Renato Talamini; Lorenzo Simonato; Ray Lowry; David I Conway; Ariana Znaor; Claire Healy; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

9.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

10.  [Lung cancer. Epidemiology and etiologic factors].

Authors:  N Frusch; L Bosquée; R Louis
Journal:  Rev Med Liege       Date:  2007-09
View more
  9 in total

1.  Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.

Authors:  T Wang; T Chen; A Thakur; Y Liang; L Gao; S Zhang; Y Tian; T Jin; J J Liu; M Chen
Journal:  Clin Transl Oncol       Date:  2015-03-06       Impact factor: 3.405

2.  Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population.

Authors:  Ying Wang; Yongjun Zhang; Cuiping Gu; Wenlong Bao; Yejiang Bao
Journal:  Med Oncol       Date:  2014-03-28       Impact factor: 3.064

3.  Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study.

Authors:  Ying Wang; Weiyu Jiang; Xiaogu Liu; Yongjun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  The CHRNA5 Polymorphism (rs16969968) and its Association with Waterpipe Smoking Addiction among Jordanians.

Authors:  Thaka'a K Al-Omoush; Karem H Alzoubi; Omar F Khabour; Fawzi M Alsheyab; Ahmed Abu-Siniyeh; Nour A Al-Sawalha; Fadia A Mayyas; Caroline O Cobb; Thomas Eissenberg
Journal:  Arab J Basic Appl Sci       Date:  2020-11-24

5.  Analyzing large-scale samples confirms the association between the rs1051730 polymorphism and lung cancer susceptibility.

Authors:  Zhijie Han; Qinghua Jiang; Tianjiao Zhang; Xiaoliang Wu; Rui Ma; Jixuan Wang; Yang Bai; Rongjie Wang; Renjie Tan; Yadong Wang
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

6.  CHRNA3 polymorphism modifies lung adenocarcinoma risk in the Chinese Han population.

Authors:  Ping He; Xue-Xi Yang; Xuan-Qiu He; Jun Chen; Fen-Xia Li; Xia Gu; Ju-Hong Jiang; Hui-Ying Liang; Guang-Yu Yao; Jian-Xing He
Journal:  Int J Mol Sci       Date:  2014-03-28       Impact factor: 5.923

7.  Impact of CHRNA5 polymorphisms on the risk of schizophrenia in the Chinese Han population.

Authors:  Dafei Zhan; Qiankun Yao; Shaojian Fu; Xianglai Liu; Jun Zhou; Daqiang Chen; Chuanlong Yu
Journal:  Mol Genet Genomic Med       Date:  2019-07-24       Impact factor: 2.183

8.  Association between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis.

Authors:  Xiao Qu; Kai Wang; Wei Dong; Hongchang Shen; Ying Wang; Qi Liu; Jiajun Du
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

9.  Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.

Authors:  Yalei Zhang; Mei Jiang; Qin Li; Wenhua Liang; Qihua He; Weiqing Chen; Jianxing He
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.